Patents by Inventor Remy Luthringer

Remy Luthringer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING SCHIZOPHRENIA
    Publication number: 20170042877
    Abstract: The disclosure provides a novel polymorph of Compound (I): 2-((1-(2-(4-Fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one monohydrochloride dihydrate, i.e., Form (A) of Compound (I).HCl.2H2O. Pharmaceutical compositions comprising Form (A) of Compound (I).HCl.2H2O and related methods of treatment are also disclosed.
    Type: Application
    Filed: September 28, 2016
    Publication date: February 16, 2017
    Inventor: Remy Luthringer
  • Compositions and methods for treating schizophrenia
    Patent number: 9458130
    Abstract: The disclosure provides a novel polymorph of Compound (I): 2-((1-(2-(4-Fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one monohydrochloride dihydrate, i.e., Form (A) of Compound (I).HCl.2H2O. Pharmaceutical compositions comprising Form (A) of Compound (I).HCl.2H2O and related methods of treatment are also disclosed.
    Type: Grant
    Filed: November 30, 2015
    Date of Patent: October 4, 2016
    Assignee: Minerva Neurosciences, Inc.
    Inventor: Remy Luthringer
  • COMPOSITIONS AND METHODS FOR TREATING SCHIZOPHRENIA
    Publication number: 20160152597
    Abstract: The disclosure provides a novel polymorph of Compound (I): 2-((1-(2-(4-Fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one monohydrochloride dihydrate, i.e., Form (A) of Compound (I).HCl.2H2O. Pharmaceutical compositions comprising Form (A) of Compound (I).HCl.2H2O and related methods of treatment are also disclosed.
    Type: Application
    Filed: November 30, 2015
    Publication date: June 2, 2016
    Inventors: REMY LUTHRINGER, MASAHIRO OKUYAMA
  • METHODS OF USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION
    Publication number: 20140206722
    Abstract: Disclosed herein are compositions and methods for treating depression using compositions comprising a compound of formula I. Disclosed herein are compositions and methods for treating depression using compositions comprising phenoxypropylamine compounds and derivatives having selective affinity for and antagonistic activity against the 5-HT1A receptor, as well as 5-HT reuptake inhibitory activity. In addition, compositions and methods for treating depression using compositions comprising a compound of formula II are disclosed. Methods of treating or diminishing at least one symptom of depression in a human subject with a composition comprising a compound of the formula (I) or formula (II), or a pharmaceutically acceptable salt, hydrate, or solvate thereof, are also disclosed.
    Type: Application
    Filed: January 24, 2014
    Publication date: July 24, 2014
    Applicant: MINERVA NEUROSCIENCES, INC.
    Inventors: Lorenzo Pellegrini, Argeris Karabelas, Remy Luthringer